MCKENZIE DIANA 4

What Happened
Diana McKenzie, a director of MetLife, received an acquisition award of 189 shares of MetLife common stock on 2026-03-10 at an imputed price of $70.60 per share, valued at $13,343. This was reported on a Form 4 filed 2026-03-12. The transaction is an award/acquisition (code A), reflecting reinvestment of dividends rather than an open-market purchase.

Key Details

• Transaction date and price: 2026-03-10 at $70.60 per share. Total value ≈ $13,343.
• Transaction type: Award / Acquisition (code A) — imputed reinvestment of dividends under the MetLife Deferred Compensation Plan for Non-Management Directors (see footnote).
• Shares owned after transaction: not specified in the filing.
• Filing timeliness: Form 4 filed 2026-03-12 for a 2026-03-10 transaction (timely within the usual two-business-day window).
• Footnote: Deferred shares represent shares that became payable but whose receipt the director has deferred under the plan.

Context
This transaction appears to be a routine dividend reinvestment under a non-management director deferred compensation plan, not a market purchase or sale. Such awards are common and are typically administrative in nature rather than a direct signal of insider sentiment.